Captor Therapeutics Spolka Akcyjna

BST:60Q Stock Report

Market Cap: €51.9m

Captor Therapeutics Spolka Akcyjna Balance Sheet Health

Financial Health criteria checks 5/6

Captor Therapeutics Spolka Akcyjna has a total shareholder equity of PLN41.1M and total debt of PLN0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are PLN64.6M and PLN23.5M respectively.

Key information

0%

Debt to equity ratio

zł0

Debt

Interest coverage ration/a
Cashzł48.82m
Equityzł41.11m
Total liabilitieszł23.52m
Total assetszł64.63m

Recent financial health updates

No updates

Recent updates

Financial Position Analysis

Short Term Liabilities: 60Q's short term assets (PLN55.2M) exceed its short term liabilities (PLN20.8M).

Long Term Liabilities: 60Q's short term assets (PLN55.2M) exceed its long term liabilities (PLN2.7M).


Debt to Equity History and Analysis

Debt Level: 60Q is debt free.

Reducing Debt: 60Q had no debt 5 years ago.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: 60Q has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: Insufficient data to determine if 60Q has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.


Discover healthy companies